Neuroscience

New anti-ALS drug receives Orphan Drug designation

A new gene therapy for treating an inherited form of Amyotrophic Lateral Sclerosis has been given an Orphan Drug designation by the European Medicines Agency. The therapy is already in preclinical development at EPFL.

Psychology & Psychiatry

Schizophrenics' blood has more genetic material from microbes

The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found.

Immunology

Immune cells hold promise in slowing down ALS

Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive ...

Health

Extreme exercisers may have higher odds for ALS

(HealthDay)—Fitness buffs who push themselves to the limit during workouts might slightly increase their risk of developing amyotrophic lateral sclerosis (ALS), a new study suggests.

page 36 from 40